PUBLISHER INDEPENDENCE DISCLAIMER: This article was prepared as promotional content by a party with an affiliate relationship to the product discussed
Gorgojo-Martnez JJ, Serrano-Moreno C, Sanz-Velasco A, Feo-Ortega G, Almodvar-Ruiz F
In an effort to inform solutions for optimizing GLP-1 adherence and outcomes, Omada Insights Lab published an analysis of early behaviors and outcomes of members who self-disclosed that they were taking a GLP-1 for weight loss, and opted in to Omadas Enhanced GLP-1 Care Track
Understanding the differences between diabetes indications, obesity indications, and secondary indications can significantly improve approval rates
NMR Studies on the Surface Accessibility of the Archaeal Protein Sso7d by Using TEMPOL and Gd(III)(DTPA-BMA) as Paramagnetic Probes
Still, as more clinical studies test the effects of semaglutide on age-related diseases, we may find that this GLP-1 receptor agonists to be a true anti-aging agent
